Wellington Hospital, Capital & Coast District Health Board
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Weinkove, Robert
BRUIN-CLL-314, NCT05254743 / 2021-003206-41: A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Active, not recruiting
3
650
Europe, Canada, Japan, US, RoW
Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib
Loxo Oncology, Inc., Eli Lilly and Company
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
06/25
01/28
ENABLE-2, NCT06486051: A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Recruiting
2
60
RoW
Fludarabine, Cyclophosphamide, WZTL-002 CAR T-cells, 1928T2z CAR T-cells
Malaghan Institute of Medical Research, BioOra Limited, Wellington Zhaotai Therapies Limited
Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Non-Hodgkin Lymphoma
06/26
06/28
ENABLE, NCT04049513: -1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Active, not recruiting
1
30
RoW
WZTL002-1 (1928T2z CAR-T cells), Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
Malaghan Institute of Medical Research, Wellington Zhaotai Therapies Limited
Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL)
06/24
03/29
George, Philip E
ENABLE-2, NCT06486051: A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Recruiting
2
60
RoW
Fludarabine, Cyclophosphamide, WZTL-002 CAR T-cells, 1928T2z CAR T-cells
Malaghan Institute of Medical Research, BioOra Limited, Wellington Zhaotai Therapies Limited
Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Non-Hodgkin Lymphoma
06/26
06/28
ENABLE, NCT04049513: -1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Active, not recruiting
1
30
RoW
WZTL002-1 (1928T2z CAR-T cells), Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
Malaghan Institute of Medical Research, Wellington Zhaotai Therapies Limited
Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL)
06/24
03/29
D'Souza, Alwyn AB
ENABLE, NCT04049513: -1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Active, not recruiting
1
30
RoW
WZTL002-1 (1928T2z CAR-T cells), Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
Malaghan Institute of Medical Research, Wellington Zhaotai Therapies Limited
Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL)
06/24
03/29
Perera, Travis N
ENABLE, NCT04049513: -1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Active, not recruiting
1
30
RoW
WZTL002-1 (1928T2z CAR-T cells), Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
Malaghan Institute of Medical Research, Wellington Zhaotai Therapies Limited
Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL)
06/24
03/29

Download Options